Three-dimensionally Printed Hyrax Versus Conventional Hyrax for Maxillary Arch Expansion in Adolescents
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-17
SponsorAin Shams University
About this trial
This clinical trial aims to compare the skeletal and dental effects of conventional Hyrax expanders and 3D-printed Hyrax expanders in adolescent patients with maxillary transverse deficiency. Using cone-beam computed tomography (CBCT) and digital models, the study evaluates the precision, customization, and treatment outcomes of both appliance types to inform evidence-based orthodontic treatment planning.
Eligibility criteria
Qualifiers
Patients aged between 12 to 17 years.
Skeletal age ranges from CVMS 3 to CVMS 5.
Skeletal maxillary transverse deficiency with/without crossbite.
Cooperative and able to attend follow-up visits.
Disqualifiers
Previous orthodontic treatment.
Craniofacial syndromes, or cleft lip and/or palate.
Patients with vertical growth pattern.
Very bad oral hygiene and active periodontal disease.
Trial design
Treatments tested in this trial
- Three dimensionally printed hyrax expander
- Conventionally Fabricated Hyrax Expander
Treatment groups
22 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov